Skip to main content

SBIO

ETF
—
—

Performance overview

SBIO Price
Price Chart

Forward-looking statistics

Beta
1.15
Risk
28.55%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Fund Profile

The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials.

Fund info

The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials.

Investing methodPassively Managed
DiversifiedNo
Expense ratio0.60%
Asset classUnknown

Company info

Sector—
Industry—
Website—
AUM—

Security info

ExchangeNyse American
Type of shareN/A
Earnings per share (EPS)—
Dividend per share—
Revenue per share—
Avg trading volume (30 day)$685K
Avg trading volume (10 day)$1M
Put-call ratioN/A

Macro factor sensitivity

Growth+1.1
Credit+4.9
Liquidity+0.2
Inflation-2.2
Commodities-0.5
Interest Rates-1.5

Upcoming events

Next earnings day—
Next dividend day—
Ex. dividend dayDecember 19, 2024

News

Small-Cap ETFs to Rally on Upbeat U.S. Q2 GDP Growth Data?

The US economy expanded at a faster-than-expected pace in the second quarter of 2024. Small-cap stocks generally lead the way higher on improving American economy.

Zacks Investment Research (July 26, 2024)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free